BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14512412)

  • 1. Temozolomide: too early for definitive conclusions.
    Brown P; Buckner J
    J Clin Oncol; 2003 Oct; 21(19):3710. PubMed ID: 14512412
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
    Wen PY
    J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652
    [No Abstract]   [Full Text] [Related]  

  • 3. Temozolomide in malignant gliomas: current use and future targets.
    Villano JL; Seery TE; Bressler LR
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):647-55. PubMed ID: 19543728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide.
    Yaman E; Buyukberber S; Benekli M; Oner Y; Coskun U; Akmansu M; Ozturk B; Kaya AO; Uncu D; Yildiz R
    Clin Neurol Neurosurg; 2010 Oct; 112(8):662-7. PubMed ID: 20627551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral hemorrhage secondary to thrombocytopenia in a patient treated with temozolomide.
    Sure D; Dunn I; Norden A; Anderson WS
    Clin Neurol Neurosurg; 2010 Oct; 112(8):741-2. PubMed ID: 20434832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
    Brandsma D; Stalpers L; Taal W; Sminia P; van den Bent MJ
    Lancet Oncol; 2008 May; 9(5):453-61. PubMed ID: 18452856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers.
    Stupp R; Hottinger AF; van den Bent MJ; Dietrich PY; Brandes AA
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii209-16. PubMed ID: 18790951
    [No Abstract]   [Full Text] [Related]  

  • 8. Promises and controversies in the management of low-grade glioma.
    Stupp R; Baumert BG
    Ann Oncol; 2003 Dec; 14(12):1695-6. PubMed ID: 14630671
    [No Abstract]   [Full Text] [Related]  

  • 9. Is protracted low-dose temozolomide feasible in glioma patients?
    Wong ET
    Neurology; 2006 Aug; 67(3):543-4; author reply 543-4. PubMed ID: 16894133
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of malignant glioma--quo vadis?
    Stupp R; Hottinger AF
    Onkologie; 2008 Jun; 31(6):300-2. PubMed ID: 18547969
    [No Abstract]   [Full Text] [Related]  

  • 12. Temozolomide for pediatric high-grade gliomas.
    Packer RJ
    Curr Neurol Neurosci Rep; 2012 Apr; 12(2):111-3. PubMed ID: 22249491
    [No Abstract]   [Full Text] [Related]  

  • 13. Delirium likely caused by interaction between phenytoin and temozolomide.
    Levy M
    Psychosomatics; 2007; 48(4):359-60. PubMed ID: 17600176
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular pharmacology on DNA methylating agent temozolomide].
    Hirose Y; Sano H
    No Shinkei Geka; 2007 Feb; 35(2):117-29. PubMed ID: 17310751
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous administration of temozolomide as a useful alternative over oral treatment with temozolomide capsules in patients with gliomas.
    Motomura K; Natsume A; Wakabayashi T
    J Neurooncol; 2012 Jan; 106(1):209-11. PubMed ID: 21725854
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid desensitization with temozolomide in patients with delayed maculopapular rash.
    Alonso-Llamazares A; Vega-Castro A; Beitia-Mazuecos JM; Mateo-Borrega B; Cardenas-Contreras R
    J Investig Allergol Clin Immunol; 2012; 22(6):448-9. PubMed ID: 23101195
    [No Abstract]   [Full Text] [Related]  

  • 17. Temozolomide for malignant brain tumours.
    Batchelor T
    Lancet; 2000 Apr; 355(9210):1115-6. PubMed ID: 10791369
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma.
    Huang J; DeWees TA; Badiyan SN; Speirs CK; Mullen DF; Fergus S; Tran DD; Linette G; Campian JL; Chicoine MR; Kim AH; Dunn G; Simpson JR; Robinson CG
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1000-1007. PubMed ID: 26025775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems of chemotherapy for glioma].
    Hirose Y
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):923-6. PubMed ID: 21751527
    [No Abstract]   [Full Text] [Related]  

  • 20. Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitis.
    Friedman HS
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):35-40. PubMed ID: 10866348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.